首页> 外文期刊>Journal of Pharmaceutical Health Care and Sciences >Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments
【24h】

Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments

机译:抗精神病药对日语不利药物事件报告数据库和基于细胞实验的分析

获取原文
       

摘要

Background Since antipsychotics induce hyperprolactinemia via the dopamine D 2 receptor, long-term administration may be a risk factor for developing breast tumors, including breast cancer. On the other hand, some antipsychotic drugs have been reported to suppress the growth of breast cancer cells in vitro. Thus, it is not clear whether the use of antipsychotics actually increases the risk of developing or exacerbating breast tumors. The purpose of this study was to clarify the effects of antipsychotic drugs on the onset and progression of breast tumors by analyzing an adverse event spontaneous reporting database and evaluating the proliferation ability of breast cancer cells. Methods Japanese Adverse Drug Event Report database (JADER) reports from April 2004 to April 2019 were obtained from the Pharmaceuticals and Medical Devices Agency ( PMDA) website. Reports of females only were analyzed. Adverse events included in the analysis were hyperprolactinemia and 60 breast tumor-related preferred terms. The reporting odds ratio (ROR), proportional reporting ratio (PRR), and information component (IC) were used to detect signals. Furthermore, MCF-7 cells were treated with haloperidol, risperidone, paliperidone, sulpiride, olanzapine and blonanserin, and cell proliferation was evaluated by WST-8 assay. Results In the JADER analysis, the IC signals of hyperprolactinemia were detected with sulpiride (IC, 3.73; 95% CI: 1.81–5.65), risperidone (IC, 3.69; 95% CI: 1.71–5.61), and paliperidone (IC, 4.54; 95% CI: 2.96–6.12). However, the IC signal of breast tumors was not observed with any antipsychotics. In cell-based experiments, MCF-7 cells were treated with six antipsychotics at concentrations of 2 and 32?μM, and none of the drugs showed any growth-promoting effects on MCF-7 cells. On the other hand, blonanserin markedly suppressed the growth of MCF-7 cells at a concentration of 32?μM, and the effect was concentration dependent. Conclusions Analysis of the JADER using the IC did not show breast tumor signals due to antipsychotic drugs. In in vitro experiments, antipsychotics did not promote MCF-7 cell proliferation whereas blonanserin suppressed MCF-7 cell growth. Further research on the effects of blonanserin on the onset and progression of breast tumor is expected.
机译:背景,由于抗精神病药通过多巴胺D 2受体诱导高催乳素血症,因此长期给药可能是发育乳腺癌的危险因素,包括乳腺癌。另一方面,据报道,一些抗精神病药物抑制体外乳腺癌细胞的生长。因此,目前尚不清楚抗精神病药是否实际上增加了乳腺肿瘤的风险。本研究的目的是通过分析自发性报告数据库并评估乳腺癌细胞的增殖能力,阐明抗精神病药物对乳腺肿瘤发作和进展的影响。方法采用2004年4月至2019年4月的日本不利药物事件报告数据库(JADER)报告是从制药和医疗器械机构(PMDA)网站获得的。仅分析了对女性的报告。分析中包含的不良事件是高催乳素血症和60例乳腺肿瘤相关的优选条款。报告赔率比(ROR),比例报告比(PRR)和信息组件(IC)用于检测信号。此外,用氟哌啶醇,立体酮,求助酮,硫化物,奥氮萘葡萄球菌,奥氮萘葡萄球菌,奥氮萘葡萄球菌,奥氮萘葡萄球菌和Blonanserin处理MCF-7细胞,并通过WST-8测定评估细胞增殖。结果在JADER分析中,用巯基(IC,3.73; 95%CI:1.81-5.65),Risperidone(IC,3.69; 95%CI:1.71-5.61)和Paliperidone(IC,4.54 ; 95%CI:2.96-6.12)。然而,没有用任何抗精神病药观察到乳腺肿瘤的IC信号。在基于细胞的实验中,用浓度为2和32Ω·μm的六个抗精神病药处理MCF-7细胞,并且没有任何药物对MCF-7细胞显示出任何生长促进作用。另一方面,Blonanserin明显抑制了MCF-7细胞的生长,浓度为32Ωμm,效果浓度依赖性。结论使用IC的Jader分析由于抗精神病药物而没有显示乳腺肿瘤信号。在体外实验中,抗精神病药没有促进MCF-7细胞增殖,而Blonanserin抑制了MCF-7细胞生长。预期进一步研究Blonanserin对乳腺肿瘤发作和进展的进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号